Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substa… — frequently asked

What are the odds for "Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?" on Polymarket?

Polymarket traders currently price it at Yes 14% · No 86%. Polymarket prices are implied probabilities: a share that pays $1 if the outcome happens trades at its probability in cents. Resolves by Jan 1, 2027.

Who is the smart money on "Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?"?

Polynyx ranks every Polymarket wallet by realized profit and consistency and shows which side the ranked wallets hold on this market, their average entry and how much they have invested. Premium opens every smart wallet by name, with its P&L and full trade history.

How much has been traded on "Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?"?

24h volume $62, liquidity $2.2K, $3.2K traded all-time. Volume and liquidity come straight from Polymarket; Polynyx adds the holder book, the live trade tape and whale-size flags on each trade.

Can I build my own dashboard for "Will the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?"?

Yes. Polydune turns this market into a no-code dashboard — odds over time, smart money by side, holders and the tape as widgets you arrange yourself — and keeps it live from the same Polynyx data. Open the market on Polydune and use the template.